• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - COSTA RICA (COYOL) OPTICROSS¿ 18; CATHETER, ULTRASOUND, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - COSTA RICA (COYOL) OPTICROSS¿ 18; CATHETER, ULTRASOUND, INTRAVASCULAR Back to Search Results
Model Number H7493932800180
Device Problem Entrapment of Device (1212)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/18/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
Same case as: 2134265-2017-06032.It was reported that catheter entanglement occurred.Vascular access was obtained via the right brachial artery.The target lesion was located in the right iliac artery.An opticross¿ 18 imaging catheter was selected for use.During the procedure, a 5f 11cm super sheath was placed in the right brachial artery then a 5f 100cm imager ii diagnostic catheter was inserted to reach right iliac artery which had a stent placed previously.A v-18¿ control wire was then placed in order to use the opticross¿ 18 imaging catheter to view the lesion.However, the opticross¿ 18 imaging catheter was first recognized as an ultra ice plus ¿ imaging catheter.A few disconnection and reconnection were attempted, but the issue was not resolved.The ilab system was shut down and restarted and the opticross¿ 18 imaging catheter was finally recognized correctly.While the opticross¿ 18 was in use, the device failed to cross the iliac artery where the previously implanted stent was placed.As the opticross¿ 18 imaging catheter did not have enough rail support, this resulted to the opticross¿ 18 and the v-18¿ control wire to loop within the artery.After a couple of attempts to resolve the issue, the screen went blank and the physician decided to abandon the use of opticross.No patient complications were reported.
 
Manufacturer Narrative
Device evaluated by manufacturer: the device was returned for analysis.Device analysis revealed a damage on the guidewire exit port assembly.No damages or failures were observed on the ccp board assembly.No other visual damages were encountered upon visual inspection.The telescope assembly was able to properly pull back, advance, and retract.A test guidewire was inserted and no indication of resistance in tracking the guidewire into the catheter was noted.The catheter was properly recognized by the imaging system when plugged into the motordrive unit (mdu) and no connection issues or errors were detected during its testing.It was observed that the catheter flushed normally when the imaging core was fully retracted and fully advanced.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is operational context as device performance was limited due to anatomical procedural factors.(b)(4).
 
Event Description
It was reported that catheter entanglement occurred.Vascular access was obtained via the right brachial artery.The target lesion was located in the right iliac artery.An opticross 18 imaging catheter was selected for use.During the procedure, a 5f 11cm super sheath was placed in the right brachial artery then a 5f 100cm imager ii diagnostic catheter was inserted to reach right iliac artery which had a stent placed previously.A v-18 control wire was then placed in order to use the opticross 18 imaging catheter to view the lesion.However, the opticross 18 imaging catheter was first recognized as an ultra ice plus imaging catheter.A few disconnection and reconnection were attempted, but the issue was not resolved.The ilab system was shut down and restarted and the opticross 18 imaging catheter was finally recognized correctly.While the opticross 18 was in use, the device failed to cross the iliac artery where the previously implanted stent was placed.As the opticross 18 imaging catheter did not have enough rail support, this resulted to the opticross 18 and the v-18 control wire to loop within the artery.After a couple of attempts to resolve the issue, the screen went blank and the physician decided to abandon the use of opticross.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTICROSS¿ 18
Type of Device
CATHETER, ULTRASOUND, INTRAVASCULAR
Manufacturer (Section D)
BOSTON SCIENTIFIC - COSTA RICA (COYOL)
2546 first street
propark free zone
alajuela
CS 
Manufacturer (Section G)
BOSTON SCIENTIFIC - COSTA RICA (COYOL)
2546 first street
propark free zone
alajuela
CS  
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6607725
MDR Text Key76519720
Report Number2134265-2017-05651
Device Sequence Number1
Product Code ITX
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
TBD
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/18/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/02/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/08/2019
Device Model NumberH7493932800180
Device Lot Number20379343
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/24/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/12/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/10/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-